Navigation Links
Lung cancer conference to focus on new diagnostic techniques, potential treatments
Date:1/5/2012

SAN DIEGO -- Lung cancer is the most commonly diagnosed cancer in the United States and often the most fatal unless caught early, but scientists are working on ways to improve their understanding of the disease.

Several hundred of scientists will gather in San Diego at the San Diego Marriott Marquis & Marina during Jan. 8-11, 2012, for the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine.

The conference is jointly sponsored by the American Association for Cancer Research and the International Association for the Study of Lung Cancer.

Media are welcome to attend the conference and can register by contacting Jeremy Moore at Jeremy.Moore@aacr.org.

The conference will host a media briefing, entitled "Lung Cancer Diagnosis: Pitfalls, Challenges and the Path Ahead," on Tuesday, Jan. 10 at 1:00 p.m. PT (4:00 p.m. ET). The briefing will be held in the Atlanta/Chicago room of the San Diego Marriott Marquis & Marina.

The following leaders in lung cancer are scheduled to speak at the press conference:

  • Roy Herbst, M.D., Ph.D., chief of medical oncology and associate director for translational research at the Yale Cancer Center;
  • David P. Carbone, M.D., Ph.D., Harold L. Moses chair in cancer research, director of the Specialized Program of Research Excellence in Lung Cancer and co-leader of the Thoracic/Head and Neck Research Program at the Vanderbilt-Ingram Cancer Center; and
  • Paul A. Bunn, M.D., professor and James Dudley chair in cancer research at the University of Colorado School of Medicine.

Reporters who cannot attend in person can participate using the following information:

U.S./Canada (Toll Free): 888-647-7462

International (Toll): 201-604-0169

Conference leaders have also designated the following research as newsworthy:

  • Estrogen-Targeting Drug Combo May Help Prevent Lung Cancer
  • Researchers Map Potential Genetic Origins, Pathways of Lung Cancer in Never-Smokers
  • Ganetespib Showed Activity in KRAS-Mutant NSCLC as Monotherapy and in Combinations
  • Precancer Markers Identified in Airway Epithelium Cells of Healthy Smokers
  • Sorafenib Effective in Patients With Non-Small Cell Lung Cancer, but Low Survival Rates Reported
  • Sensitive Detection Method Analyzes Circulating Tumor Cells in Patients With Lung Cancer
  • Genetic Composition of Multicentric Lung Tumors Appears to be Similar


'/>"/>
Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. MU researchers photoacoustic device finds cancer cells before they become tumors
2. New stage in fighting pancreatic cancer
3. Gene identified in increasing pancreatic cancer risk
4. Cleveland Clinic researcher discovers genetic cause of thyroid cancer
5. Penn engineers develop more effective MRI contrast agent for cancer detection
6. Drugs used to overcome cancer may also combat antibiotic resistance: McMaster researchers
7. Potential anti-cancer treatment method wins Kaye Award
8. Wayne State study finds soybean compounds enhances effects of cancer radiotherapy
9. Cancer from fetal exposure to carcinogens depends on dose, timing
10. AACR & IASLC to host molecular origins of lung cancer conference
11. London researchers lead innovative new cancer treatment study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/28/2016)... JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: SYNA ... results for its second quarter ended December 31, 2015. ... second quarter of fiscal 2016 increased 2 percent compared to the ... second quarter of fiscal 2016 was $35.0 million, or $0.93 per ... Non-GAAP net income for the first quarter of fiscal 2016 grew ...
(Date:1/22/2016)... , January 22, 2016 ... the addition of the  "Global Behavioral ... offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ... "Global Behavioral Biometric Market 2016-2020"  report ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ...
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... significant achievements are the result of the company,s laser ... iMedNet eClinical , it,s comprehensive, easy-to-use and highly ... --> Key MedNet growth achievements in 2015 ...
Breaking Biology News(10 mins):
(Date:2/9/2016)... (PRWEB) , ... February 08, 2016 , ... ... p.m. , Location: Baruch S. Blumberg Institute at the Pennsylvania Biotechnology Center of ... Blumberg Institute and The Commonwealth Medical College (TCMC) will hold an open house ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... its latest innovations on its free and validated Electronic Data Capture (EDC) system ... the Outsourcing in Clinical Trials West Coast 2016 Conference in San Mateo, California ...
(Date:2/9/2016)... SC (PRWEB) , ... February 09, 2016 , ... The ... in the organization’s history, it is offering its 2016 AAT Member Certification Qualification Course ... , The curriculum for the webinar, which will include a detailed review of hardware, ...
(Date:2/9/2016)... ... 2016 , ... PharmApprove announced today the hiring ... for Rare Disorders (NORD). Dorman will lead PharmApprove efforts to work with patients, ... drug regulatory review process. , “Adding Diane Dorman is just the latest in ...
Breaking Biology Technology: